Zydus Lifesciences has introduced ANVIMO, a breakthrough medication for preventing Cytomegalovirus (CMV) infection in haematopoietic stem cell and kidney transplant patients. The drug, containing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback